Drawing for NEWGENE

USPTO serial 97231267

NEWGENE

Status 641Office Action
Filing date
Jan 21, 2022
Status date
Jul 27, 2026
Registration date
Examiner
KUNKLEMAN, SARAH E

Need help with NEWGENE?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: 27 Oct 2026

Office Action issues

The USPTO requires us to appoint a U.S.-licensed attorney for you, and has temporarily deferred the search for conflicting marks while your application undergoes administrative review.

Owner

  • New Gene (Hangzhou) Bioengineering Co., Ltd.

    Hangzhou, Zhejiang,, CN

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for magnet therapy; Blood testing apparatus; Body composition analyzers for medical purposes; Body composition monitors; Electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression; Inhalers for medical use; Needles for medical purposes; Surgical apparatus and instruments for medical, dental or veterinary use; Syringes for medical purposes; Urological imaging systemsACTIVEDec 1, 2021

Prosecution history

DateCodeEvent
Aug 27, 2026DOCKASSIGNED TO EXAMINER
Jul 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2026GNRTNON-FINAL ACTION E-MAILED
Jul 27, 2026CNRTNON-FINAL ACTION WRITTEN
Jul 20, 2026DOCKASSIGNED TO EXAMINER
Jul 7, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED
Jul 7, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jan 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022NWAPNEW APPLICATION ENTERED

Related guidance